673 related articles for article (PubMed ID: 9777318)
1. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
Langtry HD; Lamb HM
Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Hurst M; Lamb HM; Scott LJ; Figgitt DP
Drugs; 2002; 62(14):2127-67. PubMed ID: 12269858
[TBL] [Abstract][Full Text] [Related]
4. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Martin SJ; Jung R; Garvin CG
Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
[TBL] [Abstract][Full Text] [Related]
5. Gatifloxacin: a review of its use in the management of bacterial infections.
Perry CM; Ormrod D; Hurst M; Onrust SV
Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
[TBL] [Abstract][Full Text] [Related]
6. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Scheen AJ
Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
[TBL] [Abstract][Full Text] [Related]
9. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Scott LJ; Ormrod D; Goa KL
Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
[TBL] [Abstract][Full Text] [Related]
11. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.
Onrust SV; Lamb HM; Balfour JA
Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
Balfour JA; Lamb HM
Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
[TBL] [Abstract][Full Text] [Related]
13. Gatifloxacin.
Perry CM; Barman Balfour JA; Lamb HM
Drugs; 1999 Oct; 58(4):683-96; discussion 697-8. PubMed ID: 10551438
[TBL] [Abstract][Full Text] [Related]
14. A critical review of the fluoroquinolones: focus on respiratory infections.
Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
[TBL] [Abstract][Full Text] [Related]
15. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Perry CM; Scott LJ
Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
[TBL] [Abstract][Full Text] [Related]
16. [Levofloxacin and other fluoroquinolones in therapy of respiratory tract infections].
Płusa T
Pol Merkur Lekarski; 2011 Feb; 30(176):91-6. PubMed ID: 21544977
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin, a second-generation fluoroquinolone.
North DS; Fish DN; Redington JJ
Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
Davis R; Bryson HM
Drugs; 1994 Apr; 47(4):677-700. PubMed ID: 7516863
[TBL] [Abstract][Full Text] [Related]
19. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
[TBL] [Abstract][Full Text] [Related]
20. [Role of levofloxacin in the treatment of urinary tract infections].
Trinchiere A
Arch Ital Urol Androl; 2001 Jun; 73(2):105-13. PubMed ID: 11758533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
